S&P 500 Gains & Losses Today: Stocks Fall for Second Day as Palantir, Pharmaceuticals Drop
1. PLTR stock dropped 12% after earnings report disappointed investors. 2. Despite a 39% revenue increase, PLTR's earnings failed to impress. 3. Analysts questioned PLTR’s valuation due to significant recent price rises. 4. Overall market declines impacted stocks, including PLTR and other tech firms. 5. Tariff policy changes may further influence PLTR's market performance.